Iovance Biotherapeutics : Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements with Certain Officers (Form 8-K)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements with Certain Officers.

On September 22, 2021, the Board of Directors (the "Board") of Iovance Biotherapeutics, Inc. (the "Company") adopted the Iovance Biotherapeutics, Inc. 2021 Inducement Plan (the "2021 Inducement Plan"). The 2021 Inducement Plan provides for the grant of non-qualified stock options, restricted stock units and other equity awards, as described in further detail therein. The 2021 Inducement Plan was recommended for approval by the Compensation Committee of the Board (the "Compensation Committee"), and subsequently approved and adopted by the Board without stockholder approval pursuant to Rule 5635(c)(4) of the rules and regulations of The Nasdaq Stock Market, LLC (the "Nasdaq Listing Rules").

The Board has reserved 1,000,000 shares of the Company's common stock for issuance pursuant to equity awards granted under the 2021 Inducement Plan, and the 2021 Inducement Plan will be administered by the Compensation Committee of the Board. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, equity awards under the 2021 Inducement Plan may only be made to an employee who has not previously been an employee or member of the Board (or any parent or subsidiary of the Company), or following a bona fide period of non-employment by the Company (or a parent or subsidiary of the Company), if he or she is granted such equity awards in connection with his or her commencement of employment with the Company or a subsidiary and such grant is an inducement material to his or her entering into employment with the Company or such subsidiary.

A complete copy of the 2021 Inducement Plan, the Form of Stock Option Grant Notice and Stock Option Agreement to be used thereunder, and the Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement are filed herewith as Exhibits 10.1,10.2 and 10.3, respectively, and are incorporated herein by reference. The above description of the 2021 Inducement Plan and 2021 Inducement Plan documents does not purport to be complete and is qualified in its entirety by reference to Exhibits 10.1, 10.2 and 10.3.

Financial Statements and Exhibits.

(d)Exhibits.

Exhibit Number	Description
10.1	Iovance Biotherapeutics, Inc. 2021 Inducement Plan.
10.2	Form of Stock Option Grant Notice and Stock Option Agreement under the 2021 Inducement Plan.
10.3	Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the 2021 Inducement Plan.
104	Cover Page Interactive Data File - the cover page interactive date file does not appear in the Interactive Date File because its XBRL tags are embedded within the Inline XBRL document.